Global Edoxaban Tosilate Tablets and Generic Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Edoxaban Tosilate Tablets and Generic Drugs market size was valued at US$ 1791 million in 2023 and is forecast to a readjusted size of USD 2524 million by 2030 with a CAGR of 4.7% during review period.

Edoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. By inhibiting factor Xa, a key protein in the coagulation cascade, edoxaban prevents the stepwise amplification of protein factors needed to form blood clots. It is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant. Traditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for regular monitoring and INR testing, and numerous drug-drug and drug-food interactions. This has prompted enthusiasm for newer agents such as dabigatran, apixaban, and rivaroxaban for effective clot prevention. In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will be on lifelong therapy.

This report is a detailed and comprehensive analysis for global Edoxaban Tosilate Tablets and Generic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Edoxaban Tosilate Tablets and Generic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Edoxaban Tosilate Tablets and Generic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Edoxaban Tosilate Tablets and Generic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Edoxaban Tosilate Tablets and Generic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Edoxaban Tosilate Tablets and Generic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Edoxaban Tosilate Tablets and Generic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Edoxaban Tosilate Tablets and Generic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    30 mg
    60 mg
    Other

Market segment by Application
    Hospital
    Clinic
    Other

Major players covered
    Daiichi Sankyo
    Menarini Group
    Simcere Pharmaceutical
    Lunan Pharmaceutical Group

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Edoxaban Tosilate Tablets and Generic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Edoxaban Tosilate Tablets and Generic Drugs, with price, sales quantity, revenue, and global market share of Edoxaban Tosilate Tablets and Generic Drugs from 2019 to 2024.
Chapter 3, the Edoxaban Tosilate Tablets and Generic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Edoxaban Tosilate Tablets and Generic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Edoxaban Tosilate Tablets and Generic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Edoxaban Tosilate Tablets and Generic Drugs.
Chapter 14 and 15, to describe Edoxaban Tosilate Tablets and Generic Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 30 mg
        1.3.3 60 mg
        1.3.4 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size & Forecast
        1.5.1 Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (2019-2030)
        1.5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Daiichi Sankyo
        2.1.1 Daiichi Sankyo Details
        2.1.2 Daiichi Sankyo Major Business
        2.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product and Services
        2.1.4 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Daiichi Sankyo Recent Developments/Updates
    2.2 Menarini Group
        2.2.1 Menarini Group Details
        2.2.2 Menarini Group Major Business
        2.2.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product and Services
        2.2.4 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Menarini Group Recent Developments/Updates
    2.3 Simcere Pharmaceutical
        2.3.1 Simcere Pharmaceutical Details
        2.3.2 Simcere Pharmaceutical Major Business
        2.3.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product and Services
        2.3.4 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Simcere Pharmaceutical Recent Developments/Updates
    2.4 Lunan Pharmaceutical Group
        2.4.1 Lunan Pharmaceutical Group Details
        2.4.2 Lunan Pharmaceutical Group Major Business
        2.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product and Services
        2.4.4 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Lunan Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Edoxaban Tosilate Tablets and Generic Drugs by Manufacturer
    3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturer (2019-2024)
    3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Edoxaban Tosilate Tablets and Generic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Edoxaban Tosilate Tablets and Generic Drugs Manufacturer Market Share in 2023
        3.4.3 Top 6 Edoxaban Tosilate Tablets and Generic Drugs Manufacturer Market Share in 2023
    3.5 Edoxaban Tosilate Tablets and Generic Drugs Market: Overall Company Footprint Analysis
        3.5.1 Edoxaban Tosilate Tablets and Generic Drugs Market: Region Footprint
        3.5.2 Edoxaban Tosilate Tablets and Generic Drugs Market: Company Product Type Footprint
        3.5.3 Edoxaban Tosilate Tablets and Generic Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region
        4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2019-2030)
        4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2019-2030)
        4.1.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Region (2019-2030)
    4.2 North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030)
    4.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030)
    4.4 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030)
    4.5 South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030)
    4.6 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    5.2 Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Type (2019-2030)
    5.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    6.2 Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application (2019-2030)
    6.3 Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Application (2019-2030)

7 North America
    7.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    7.2 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    7.3 North America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
        7.3.1 North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2030)
        7.3.2 North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    8.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    8.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
        8.3.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2030)
        8.3.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Market Size by Region
        9.3.1 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    10.2 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    10.3 South America Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
        10.3.1 South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2030)
        10.3.2 South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country
        11.3.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Edoxaban Tosilate Tablets and Generic Drugs Market Drivers
    12.2 Edoxaban Tosilate Tablets and Generic Drugs Market Restraints
    12.3 Edoxaban Tosilate Tablets and Generic Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Edoxaban Tosilate Tablets and Generic Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Edoxaban Tosilate Tablets and Generic Drugs
    13.3 Edoxaban Tosilate Tablets and Generic Drugs Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Edoxaban Tosilate Tablets and Generic Drugs Typical Distributors
    14.3 Edoxaban Tosilate Tablets and Generic Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
 Table 4. Daiichi Sankyo Major Business
 Table 5. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product and Services
 Table 6. Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Daiichi Sankyo Recent Developments/Updates
 Table 8. Menarini Group Basic Information, Manufacturing Base and Competitors
 Table 9. Menarini Group Major Business
 Table 10. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product and Services
 Table 11. Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Menarini Group Recent Developments/Updates
 Table 13. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 14. Simcere Pharmaceutical Major Business
 Table 15. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product and Services
 Table 16. Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Simcere Pharmaceutical Recent Developments/Updates
 Table 18. Lunan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 19. Lunan Pharmaceutical Group Major Business
 Table 20. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product and Services
 Table 21. Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Lunan Pharmaceutical Group Recent Developments/Updates
 Table 23. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 24. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 25. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 26. Market Position of Manufacturers in Edoxaban Tosilate Tablets and Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 27. Head Office and Edoxaban Tosilate Tablets and Generic Drugs Production Site of Key Manufacturer
 Table 28. Edoxaban Tosilate Tablets and Generic Drugs Market: Company Product Type Footprint
 Table 29. Edoxaban Tosilate Tablets and Generic Drugs Market: Company Product Application Footprint
 Table 30. Edoxaban Tosilate Tablets and Generic Drugs New Market Entrants and Barriers to Market Entry
 Table 31. Edoxaban Tosilate Tablets and Generic Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 32. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 33. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2019-2024) & (K Units)
 Table 34. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2025-2030) & (K Units)
 Table 35. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 36. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 37. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Region (2019-2024) & (US$/Unit)
 Table 38. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Region (2025-2030) & (US$/Unit)
 Table 39. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 40. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 41. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Type (2019-2024) & (USD Million)
 Table 42. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Type (2025-2030) & (USD Million)
 Table 43. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Type (2019-2024) & (US$/Unit)
 Table 44. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Type (2025-2030) & (US$/Unit)
 Table 45. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 46. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 47. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application (2019-2024) & (USD Million)
 Table 48. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application (2025-2030) & (USD Million)
 Table 49. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Application (2019-2024) & (US$/Unit)
 Table 50. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Application (2025-2030) & (US$/Unit)
 Table 51. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 52. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 53. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 54. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 55. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 56. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 57. North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 58. North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 59. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 60. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 61. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 62. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 63. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 64. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 65. Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 66. Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 67. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 68. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 69. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 70. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 71. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2019-2024) & (K Units)
 Table 72. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Region (2025-2030) & (K Units)
 Table 73. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 74. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Region (2025-2030) & (USD Million)
 Table 75. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 76. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 77. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 78. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 79. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 80. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 81. South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 82. South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 83. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2019-2024) & (K Units)
 Table 84. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Type (2025-2030) & (K Units)
 Table 85. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2019-2024) & (K Units)
 Table 86. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Application (2025-2030) & (K Units)
 Table 87. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2019-2024) & (K Units)
 Table 88. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity by Country (2025-2030) & (K Units)
 Table 89. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2019-2024) & (USD Million)
 Table 90. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Country (2025-2030) & (USD Million)
 Table 91. Edoxaban Tosilate Tablets and Generic Drugs Raw Material
 Table 92. Key Manufacturers of Edoxaban Tosilate Tablets and Generic Drugs Raw Materials
 Table 93. Edoxaban Tosilate Tablets and Generic Drugs Typical Distributors
 Table 94. Edoxaban Tosilate Tablets and Generic Drugs Typical Customers


List of Figures
 Figure 1. Edoxaban Tosilate Tablets and Generic Drugs Picture
 Figure 2. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Type in 2023
 Figure 4. 30 mg Examples
 Figure 5. 60 mg Examples
 Figure 6. Other Examples
 Figure 7. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application in 2023
 Figure 9. Hospital Examples
 Figure 10. Clinic Examples
 Figure 11. Other Examples
 Figure 12. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity (2019-2030) & (K Units)
 Figure 15. Global Edoxaban Tosilate Tablets and Generic Drugs Price (2019-2030) & (US$/Unit)
 Figure 16. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Manufacturer in 2023
 Figure 17. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Manufacturer in 2023
 Figure 18. Producer Shipments of Edoxaban Tosilate Tablets and Generic Drugs by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 19. Top 3 Edoxaban Tosilate Tablets and Generic Drugs Manufacturer (Revenue) Market Share in 2023
 Figure 20. Top 6 Edoxaban Tosilate Tablets and Generic Drugs Manufacturer (Revenue) Market Share in 2023
 Figure 21. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Region (2019-2030)
 Figure 22. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 23. North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 25. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 26. South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 27. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 28. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 29. Global Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Type (2019-2030)
 Figure 30. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Type (2019-2030) & (US$/Unit)
 Figure 31. Global Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 32. Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Application (2019-2030)
 Figure 33. Global Edoxaban Tosilate Tablets and Generic Drugs Average Price by Application (2019-2030) & (US$/Unit)
 Figure 34. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 35. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 36. North America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 37. North America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 38. United States Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 39. Canada Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 40. Mexico Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 41. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 42. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 43. Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 44. Europe Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 45. Germany Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 46. France Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 47. United Kingdom Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 48. Russia Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 49. Italy Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 50. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 51. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 52. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Region (2019-2030)
 Figure 53. Asia-Pacific Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 54. China Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 55. Japan Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 56. South Korea Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 57. India Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 58. Southeast Asia Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 59. Australia Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 60. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 61. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 62. South America Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 63. South America Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 64. Brazil Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 65. Argentina Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 66. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Type (2019-2030)
 Figure 67. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Application (2019-2030)
 Figure 68. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Quantity Market Share by Country (2019-2030)
 Figure 69. Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value Market Share by Country (2019-2030)
 Figure 70. Turkey Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 71. Egypt Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 72. Saudi Arabia Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 73. South Africa Edoxaban Tosilate Tablets and Generic Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 74. Edoxaban Tosilate Tablets and Generic Drugs Market Drivers
 Figure 75. Edoxaban Tosilate Tablets and Generic Drugs Market Restraints
 Figure 76. Edoxaban Tosilate Tablets and Generic Drugs Market Trends
 Figure 77. Porters Five Forces Analysis
 Figure 78. Manufacturing Cost Structure Analysis of Edoxaban Tosilate Tablets and Generic Drugs in 2023
 Figure 79. Manufacturing Process Analysis of Edoxaban Tosilate Tablets and Generic Drugs
 Figure 80. Edoxaban Tosilate Tablets and Generic Drugs Industrial Chain
 Figure 81. Sales Channel: Direct to End-User vs Distributors
 Figure 82. Direct Channel Pros & Cons
 Figure 83. Indirect Channel Pros & Cons
 Figure 84. Methodology
 Figure 85. Research Process and Data Source

Companies Mentioned

Daiichi Sankyo
Menarini Group
Simcere Pharmaceutical
Lunan Pharmaceutical Group